Tags: Drug.

Dirucotide (also known as MBP8298) was developed by two research scientists (Dr. Kenneth G. Warren MD FRCP(C) & Ingrid Catz Senior Scientist) at the University of Alberta for the treatment of Multiple Sclerosis (MS). Dirucotide is a synthetic peptide that consists of 17 amino acids linked in a sequence identical to that of a portion of human myelin basic protein (MBP). The sequence of these 17 amino acids isH2N-Asp-Glu-Asn-Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-OH

Dirucotide.png
ATC prefix
none
CAS number
152074-97-0
IUPAC name
(L)-α-aspartyl-(L)-α-glutamyl-(L)-asparaginyl-(L)-prolyl-(L)-valyl- (L)-valyl-(L)-histidyl-(L)-phenylalanyl-(L)-phenylalanyl-(L)-lysyl- (L)-asparaginyl-(L)-isoleucyl-(L)-valyl-(L)-threonyl-(L)-prolyl- (L)-arginyl-(L)-threonine

Loading...

This page contains content from the copyrighted Wikipedia article "Dirucotide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.